1.. Introduction   {#sec1}
==================

*p*-Hydroxymandelate oxidase (Hmo) is a flavin mononucleotide (FMN)-dependent enzyme that oxidizes mandelate to benzoylformate. Its Y128F single mutant unexpectedly shows a new reactivity and is able to oxidize mandelate to benzoate via benzoylformate, a four-electron oxidation reaction that is typically catalysed by a monooxygenase. However, when using benzoylformate in place of mandelate the reaction becomes stuck in the absence or the presence of hydrogen peroxide (H~2~O~2~; Yeh *et al.*, 2019[@bb39]; Fig. 1[▸](#fig1){ref-type="fig"}). To the best of our knowledge, this is the second example after lactate monooxygenase (LMO) of an enzyme that performs a ThDP/PLP/NADPH-independent oxidative decarboxylation reaction at the expense of one molecule of O~2~ with the concomitant production of CO~2~ and H~2~O (Ghisla & Massey, 1989[@bb13]). It has been hypothesized that the H~2~O~2~ generated at the active site of LMO acts on pyruvate to form acetate by H~2~O~2~-mediated oxidative decarboxylation because the dissociation of pyruvate is a slow step (Giegel *et al.*, 1990[@bb15]; Lopalco *et al.*, 2016[@bb20]). Aside from this non-ping-pong kinetic description, how H~2~O~2~ mediates the oxidative decarboxylation of an α-ketoacid at the molecular level remains elusive (Choong & Massey, 1980[@bb7]; Ghisla & Massey, 1977[@bb12]; Lockridge *et al.*, 1972[@bb19]; Walsh *et al.*, 1973[@bb34]). It has been noted that the electron reactivity of FMN in flavin-dependent enzymes is the main factor governing the implementation of a given type of reaction by the dioxygen, substrates and enzyme--cofactor system. C4α and N5 of the isoalloxazine ring of FMN are the most reactive centers, electrophilically or nucleophilically interacting with a substrate through a covalent linkage or spatiotemporally conveying electrons during redox reactions (Walsh & Wencewicz, 2013[@bb36]). In a previous study (Yeh *et al.*, 2019[@bb39]), benzoylformate was found to be able to adopt a *pro-R* orientation with reference to the *si* face of the iso­alloxazine ring. This structural re­orientation aligns the nucleophilic N5 or C4α-OOH of reduced FMN (FMN~red~) with an appropriate trajectory to the electrophilic α-keto carbon of the α-ketoacid, a reaction reminiscent of the suicide inhibition of monoamine oxidase by mofegiline by forming an inactive N5 adduct or the formation of indole-3-acetate in auxin biosynthesis by the NADPH flavin-dependent monooxygenase YUC via a C4α-OOH decarboxylation-assisted mechanism (Wu *et al.*, 2005[@bb38]; Stepanova *et al.*, 2011[@bb27]; Milczek *et al.*, 2008[@bb23]; Dai *et al.*, 2013[@bb8]). In this report, both biochemical and structural measures were exploited in an attempt to address how a single O atom dictates the oxidation level in the reactions catalyzed by wild-type Hmo and its Y128F mutant.

2.. Materials and methods   {#sec2}
===========================

2.1.. Cloning and protein purification   {#sec2.1}
----------------------------------------

The *hmo* gene (*orf22*) was amplified from *Amycolatopsis orientalis* genomic DNA by polymerase chain reaction and was subcloned into the expression vector pET-28a(+) to generate the protein with an N-terminal His~6~ tag. The expression plasmid was transformed into *Escherichia coli* BL21(DE3) cells by electroporation and the cells were grown on LB agar plates containing 50 µg ml^−1^ kanamycin for 16 h at 37°C. A single colony was grown overnight in 5 ml LB medium containing 50 µg ml^−1^ kanamycin at 37°C. The cell culture was used to inoculate 1 l LB medium containing 50 µg l^−1^ kanamycin. For protein expression and purification, the transformed *E. coli* cells were cultured, induced with 200 µl 1.0 *M* IPTG at an OD~600~ of 0.6 and grown for a further 24 h at 16°C. The cells were harvested by centrifugation, resuspended in 20 ml binding buffer (20 m*M* HEPES pH 7.5, 500 m*M* NaCl, 10 m*M* imidazole, 10% glycerol) and lysed using a microfluidizer or by sonication. The supernatant of the lysate after centrifugation at 16 000 rev min^−1^ for 30 min was applied onto an Ni^2+^--NTA resin column. The bound protein was sequentially washed with 10 ml binding buffer (50 m*M* HEPES pH 8, 200 m*M* NaCl, 20 m*M* imidazole) and 10 ml wash buffer (50 m*M* HEPES pH 8, 200 m*M* NaCl, 80 m*M* imidazole) before elution with 10 ml elution buffer (20 m*M* HEPES pH 8, 500 m*M* NaCl, 250 m*M* imidazole). Gel filtration was performed using an ÄKTA FPLC system equipped with a HiLoad 16/60 Superdex 200 column (Amersham Bioscience) under isocratic conditions (20 m*M* HEPES pH 8, 100 m*M* NaCl).

2.2.. Crystallization and data collection   {#sec2.2}
-------------------------------------------

The purified proteins were crystallized using the hanging-drop vapor-diffusion method. Hmo and its Y128F, Y128C and R163L mutants were concentrated to 7 mg ml^−1^ in 50 m*M* HEPES pH 8.0 buffer solution and crystallized using a solution consisting of 35% Tascimate, 0.1 *M* bis-Tris propane pH 7.0 in a 50:50 volume ratio. Crystals appeared within five days in VDX48 plates (Hampton Research) with sealant at 20°C. For Hmo and its mutants in complex with (*S*)-mandelate (SMA), benzoylformate (BF), benzoic acid (BA), phenyl­pyruvate (PPY), oxaloacetate (OAA) or mandelamide (MAAD), each crystal was soaked with 10--30 m*M* of the designated ligand dissolved in the mother solution for between 10 min and 24 h before data collection. All crystals were transferred to a solution containing cryoprotectants and flash-cooled in liquid nitrogen prior to data collection. The cryoprotectant-containing solution for Hmo and the Y128F mutant consisted of 20%(*w*/*v*) glycerol and 35% Tascimate. X-ray diffraction data were recorded at an operating temperature of 100 K using an ADSC Quantum 315 or an MX300HE CCD detector on beamlines 13B1, 13C1, 15A1 or 05A at the National Synchrotron Radiation Research Center, Taiwan or beamline 44XU at SPring-8, Japan. All of the crystals belonged to the same space group: *I*422.

2.3.. Structure determination and refinement   {#sec2.3}
----------------------------------------------

Data were indexed and scaled using the *HKL*-2000 package (Otwinowski & Minor, 1997[@bb25]). The crystal structures were determined by the molecular-replacement (MR) method using *Phaser-MR* from the *CCP*4 suite (McCoy *et al.*, 2007[@bb22]; Winn *et al.*, 2011[@bb40]). The crystal structure of hydroxyacid oxidase (PDB entry [3sgz](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=3sgz); Chen *et al.*, 2012[@bb41]) was used as the search model for solving the initial phase. The polypeptide structures were built and refined using *REFMAC* (Murshudov *et al.*, 2011[@bb50]). Subsequent iterative cycles of model building and refinement were performed using *Coot* (Emsley *et al.*, 2010[@bb10]) and *PHENIX* (Afonine *et al.*, 2012[@bb1]). All non-H atoms were refined with anisotropic displacement parameters. Both protein structures and electron-density maps were generated using *PyMOL* (DeLano, 2002[@bb9]). Detailed refinement statistics are presented in Table 1[▸](#table1){ref-type="table"}.

2.4.. Site-directed mutagenesis   {#sec2.4}
---------------------------------

The site-directed Hmo point mutants Y128C, Y128F and R163L were generated using QuikChange (Stratagene). The primers for mutant preparation are listed in [Supplementary Table S1](#suppinfoanchor). The mutations were confirmed by DNA sequencing. Each mutated protein was purified using the same protocol as used for wild-type Hmo.

2.5.. Chemoenzymatic synthesis of 5-deazaflavin mononucleotide   {#sec2.5}
----------------------------------------------------------------

To obtain 5-deazaflavin mononucleotide, the commercially available compounds 3,4-dimethylaniline, sodium cyanoboro­hydride and [d]{.smallcaps}-ribose were used as starting materials, following the synthetic procedure described in [Supplementary Scheme S1](#suppinfoanchor). Chemically synthesized deazariboflavin was purified using column chromatography, characterized by mass spectrometry or NMR and converted to catalytically active 5-deaza-FMN by riboflavin kinase. The gene coding for riboflavin kinase was amplified from the genomic DNA of *E. coli* K12 and was subcloned into a pET-28a vector to carry an N-terminal His~6~ tag. The constructed plasmid was then transformed into *E. coli* BL21(DE3) cells for overexpression. The overexpressed protein was purified using Ni^2+^--NTA affinity chromatography and concentrated to 15 mg ml^−1^. The reaction was initiated by the addition of 2 mg ml^−1^ riboflavin kinase to a reaction solution consisting of HEPES pH 7.5 with 5 m*M* ATP, 5 m*M* MgSO~4~ and 10 m*M* 5-deazariboflavin overnight. The sample solution was purified by HPLC and confirmed by mass spectrometry.

2.6.. Preparation of 5-deaza-FMN-containing Hmo and its Y128F mutant   {#sec2.6}
----------------------------------------------------------------------

The deflavination and reconstitution of Hmo and its Y128F mutant were performed on an Ni^2+^--NTA resin column by circulating a solution of HEPES buffer containing 10 m*M* deazariboflavin (Hefti *et al.*, 2003[@bb16]). The Ni^2+^--NTA resin column was loaded and saturated with a solution of the target protein at a flow rate of 0.2 ml min^−1^ using a peristaltic pump, which was installed between the sample reservoir and the column, to ensure maximal binding. Ten volumes of denaturing buffer (50 m*M* HEPES, 2 *M* potassium bromide, 2 *M* urea pH 8.0) were subsequently used to unfold Hmo or its Y128F mutant, allowing removal of the FMN prosthetic cofactor from Hmo or its Y128F mutant. On-column replacement with 5-deaza-FMN was completed by circulating a buffer solution consisting of 50 m*M* HEPES pH 8.0, 10 m*M* 5-deaza-FMN at 0.2 ml min^−1^ overnight. Hmo or its Y128F mutant containing 5-deaza-FMN was eluted using 10 ml elution buffer (20 m*M* HEPES pH 8, 200 m*M* NaCl, 250 m*M* imidazole). An analytical gel-filtration experiment using a Superdex 200 16/20 column confirmed that 5-deaza-FMN-containing Hmo (5-deaza-Hmo) and its Y128F mutant have an unchanged tetrameric state after the refolding process. The purified enzymes were concentrated to 10 mg ml^−1^ for enzymatic assays and protein crystallization.

2.7.. Enzymatic assays using 5-deaza-Hmo and its Y128F mutant   {#sec2.7}
---------------------------------------------------------------

A typical enzymatic reaction (10 µg 5-deaza-Hmo or its Y128F mutant) was carried out in 200 µl buffer solution (20 m*M* HEPES, 100 m*M* NaCl pH 7.5, 5 m*M* *S*-mandelate, benzoylformate or benzoic acid) at 25°C for 2 h. Reactions were quenched using 6 *N* HCl and subjected to HPLC-MS analysis (using an Agilent 1260 Infinity Quaternary LC module connected to a Thermo-Finnigan LTQ-XL). Analytes were separated using a reverse-phase C~18~ column (4.6 × 250 mm, 5 µm, C~18~ Prodigy, Phenomenex) at a flow rate of 1 ml min^−1^ in a mobile system programmed as a linear gradient from 2% to 40% solvent *B* against solvent *A* over 25 min followed by 98% solvent *B* for a further 8 min (solvent *A*, water with 1% formic acid; solvent *B*, acetonitrile with 1% formic acid). The data were recorded using a UV detector with the wavelength set to 254/280 nm and the mass spectrometer in positive mode.

2.8.. UV--Vis absorption measurements of reactions of Hmo and its Y128F mutant   {#sec2.8}
--------------------------------------------------------------------------------

Ultraviolet and visible absorption spectra were recorded using a Beckman spectrophotometer (DU-800). In aqueous solution, freshly prepared Hmo or its Y128F mutant (0.125 m*M* in 0.05 *M* HEPES, 0.1 *M* NaCl pH 7.5) were mixed with substrates (2.5--5 m*M*) and incubated in a quartz cuvette at ambient temperature for 2 h. The absorption spectra of the reactions were recorded from 300 to 600 nm. For the redissolved crystals/crystalloids, more than 100 crystals of Hmo or its Y128F mutant (after soaking with substrates at 5 m*M* for 2 h) were picked from hanging-drop crystallization plates and redissolved in the mother liquor in a UV quartz cuvette before spectral scanning.

3.. Results and discussion   {#sec3}
============================

3.1.. Inhibition of α-ketoacids   {#sec3.1}
---------------------------------

To investigate the mechanism of the four-electron oxidative decarboxylation reaction catalyzed by the Hmo single mutant Y128F, we first solved crystal structures of the Y128F mutant in complex with different ligands such as (*S*)-mandelate, (*S*)-2-phenylpropionate, benzoylformate, benzaldehyde and benzoate. The ternary complexes of Hmo and its Y128F mutant were then compared, whereupon it was observed that the superpositioned complexes showed no apparent structural variations between Hmo and the Y128F mutant (r.m.s.d. of \<0.1 Å; [Supplementary Fig. S2](#suppinfoanchor)) in terms of chemical conformations and spatial positions of both the proteins and ligands. When the crystals were soaked with benzoylformate, the formation of an N5-benzoyl-FMN adduct with an N5--C′α linkage was observed \[Fig. 2[▸](#fig2){ref-type="fig"}(*a*)\]. MS analysis confirmed that the benzoyl moiety was covalently linked to FMN \[Fig. 2[▸](#fig2){ref-type="fig"}(*b*)\]. When the crystals were soaked with benzaldehyde, the formation of a covalent adduct was not observed. This outcome suggests that the α-ketoacid moiety is a prerequisite for the formation of the covalent adduct, in which the decarboxylation of the terminal carboxyl group of the α-ketoacid is likely to take place after the formation of the N5--C′α linkage. Moreover, when the crystals of the Y128F mutant were soaked with (*S*)-3-phenyllactate, phenylpyruvate or phenylacetate \[Fig. 2[▸](#fig2){ref-type="fig"}(*a*)\], we observed that (*S*)-3-phenyllactate was oxidized to phenylacetate (a four-electron oxidative decarboxylation), phenylpyruvate ended up as an N5-phenylacetyl-FMN adduct and phenylacetate stayed as it was. When the crystals were soaked with oxaloacetate, an N5-malonyl-FMN adduct was found \[Fig. 2[▸](#fig2){ref-type="fig"}(*a*)\], leading overall to the conclusion that the formation of the covalent N5 adducts is α-ketoacid-dependent.

In most flavin-dependent oxidoreductases the FMN~ox~ cofactor acts as an electron sink (electrophile) that accepts electrons or hydrides conveyed from a substrate or NADH/NADPH in the reductive half-reaction. The nitroalkane oxidase from the fungus *Fusarium oxysporum* and the alkyldihydroxyacetone phosphate synthase in human fibroblasts are two rare cases in which a carbanion is generated at the active site prior to addition to N5 of the flavin cofactor as a covalent adduct (Razeto *et al.*, 2007[@bb26]; Heroux *et al.*, 2009[@bb17]). However, a question arises in the context of how two electrophiles (FMN~ox~ and α-ketoacid) are covalently associated in the Y128F mutant. One likelihood is that the α-ketoacid undergoes decarboxylation in the first instance to form a localized C′α carbanion that then acts on FMN~ox~, but an α-ketoacid that spontaneously undergoes decarboxylation is chemically untenable. The second possibility is that the *sp* ^2^ N5 atom of FMN~ox~ acts as a nucleophile, but this scenario likewise contradicts the current understanding: FMN~ox~ is a strong electrophile that accepts electrons. Nevertheless, an extra chunk of electron density at the top of N5 of FMN~ox~ was observed in unbiased difference electron-density maps, and this electron density was denser in the Y128F mutant than in the wild type \[Figs. 2[▸](#fig2){ref-type="fig"}(*c*) and 2[▸](#fig2){ref-type="fig"}(*d*)\]. This additional electron density suggests that the C4α=N5 double bond in FMN~ox~ is polarized to a C4α^+^--N5^−^ ylide (a tertiary carbocation and a tetrahedral *sp* ^3^ amine anion), as manifested by uneven wedge-shaped electron density for the π-bond \[Figs. 2[▸](#fig2){ref-type="fig"}(*c*), 2[▸](#fig2){ref-type="fig"}(*d*), 3[▸](#fig3){ref-type="fig"}(*a*) and 3[▸](#fig3){ref-type="fig"}(*b*)\]. The extent of polarization appears to be a function of an active-site perturbation ensemble (*e.g.* the point mutation), reflecting cooperative interplay of the hydrogen-bond network between water, FMN and active-site residues as well as ligands \[Figs. 3[▸](#fig3){ref-type="fig"}(*c*) and 3[▸](#fig3){ref-type="fig"}(*d*)\]. The formation of the adduct is thereby proposed to take place as follows: the *sp* ^3^ N5 atom of the polarized FMN~ox~ attacks the carbonyl C atom of the α-ketoacid to form a covalent C′α--N5 adduct, whereupon decarboxylation takes place, resulting in a localized C′α carbanion. The lone pair of the C′α carbanion subsequently hybridizes with the π orbital of N5 to reinstate the neutrality of C4α. Upon collapse of the C′α oxyanion, N5-acyl-FMN~red~ results via a series of bond rearrangements. This species has a hydroquinone-like structure, with the acyl moiety protruding out of the plane defined by the isoalloxazine ring of FMN~ox~ \[Fig. 2[▸](#fig2){ref-type="fig"}(*a*)\].

The UV--Vis spectrum of the Y128F mutant protein solution exhibits a typical FMN~ox~ absorbance profile \[two absorbances at 370 and 450 nm; Fig. 4[▸](#fig4){ref-type="fig"}(*a*), i\]. FMN~ox~ turned colorless when phenylpyruvate was added to the solution, suggesting the formation of an acyl-FMN species \[Fig. 4[▸](#fig4){ref-type="fig"}(*a*), ii\]. The spectrum is dissimilar to that observed when phenyllactate was added \[in which the two typical absorbances at 370 and 450 nm disappeared, suggesting the reduction of FMN~ox~ to FMN~red~; Fig. 4[▸](#fig4){ref-type="fig"}(*a*), iv\] by a small hump at 340 nm \[Fig. 4[▸](#fig4){ref-type="fig"}(*a*), ii\]. The redissolved solution of Y128F mutant crystals/crystalloids that had been pre-soaked with phenylpyruvate also turned colorless, with a profile similar to that in solution \[with a smaller hump at 340 nm; Fig. 4[▸](#fig4){ref-type="fig"}(*a*), iii\] (Sucharitakul *et al.*, 2007[@bb28]; Thotsaporn *et al.*, 2011[@bb30]). While O~2~ is a small hydrophobic molecule that freely diffuses through spaces and tunnels in protein matrices (Baron, McCammon *et al.*, 2009[@bb2]; Baron, Riley *et al.*, 2009[@bb3]), Hmo may have evolved a discrete channel or pockets that temporarily limit the access of O~2~ to C4α of N5-acylated isoalloxazine. The metastable N5-alkyl-FMN~red~ in aqueous solution is thus attributable to dysfunction of the charge-transfer cage in the absence of Hmo or its Y128F mutant. The inhibited Hmo and mutants identified here differ from the conventional inactivation of FMN~ox~, which requires chemically activated agents (Walsh, 1980[@bb33], 1984[@bb35]).

3.2.. 5-Deaza-FMN in oxidation   {#sec3.2}
--------------------------------

A photoreduction mechanism has been proposed for the LMO-mediated oxidative decarboxylation reaction (Ghisla & Massey, 1977[@bb12], 1989[@bb13]; Ghisla *et al.*, 1979[@bb14]), in which the reactants need to be activated by photosensitization. In the present case (Hmo and its Y128F mutant), the C4α^+^−N5^−^ ylide of FMN~ox~ appears to be the key factor. To validate this proposition, we chemoenzymatically synthesized 1 g of the FMN analog 3,10-dimethyl-5-deaza-isoalloxazine ribitol phosphate (5-deaza-FMN~ox~) following previously reported methods \[Fig. 4[▸](#fig4){ref-type="fig"}(*b*); the modified method is described in the [supporting information](#suppinfoanchor)\] (Carlson & Kiessling, 2004[@bb5]; Kittleman *et al.*, 2007[@bb18]; Mansurova *et al.*, 2008[@bb21]; Osborne *et al.*, 2000[@bb24]). Biochemically, 5-deaza-FMN-containing Hmo or its Y128F mutant is able to oxidize (*S*)-mandelate to benzoylformate but not to benzoate, confirming that the enzyme was refolded successfully as the wild type and supporting N5 as the pivotal factor in the oxidative decarboxylation reaction \[Fig. 4[▸](#fig4){ref-type="fig"}(*c*)\]. Similarly, benzoylformate but not benzoate was found in 5-deaza-FMN~ox~-containing crystals of Hmo or its Y128F mutant soaked with (*S*)-mandelate \[Figs. 4[▸](#fig4){ref-type="fig"}(*d*) and 4[▸](#fig4){ref-type="fig"}(*e*)\]. No N5-acyl adducts can be found in 5-deaza-FMN-containing crystals of Hmo or its Y128F mutant soaked with benzoylformate or phenylpyruvate at various concentrations at different time intervals. Furthermore, the lack of visible electron density at the top of C5 or between C5 and C′α of benzoylformate (4.0 Å) suggests that the C4α=C5 double bond in 5-deaza-FMN is less polarizable. Our structural interrogation supports the decarboxylation of the α-ketoacid taking place after or in concert with the formation of the C′α--N5 bond. The R163L mutant (a low-activity mutant) was further examined using the nondecarboxylable substrates α-(*S*)-mandelamide \[2-(*S*)-hydroxy-2-phenylethylamide\] or benzoylamide (2-keto-2-phenylethylamide), in which the former is oxidized to form the latter. When the R163L mutant crystals were soaked with benzoylamide, an α-hydroxyamide-FMN adduct was formed \[Fig. 4[▸](#fig4){ref-type="fig"}(*f*)\], leading to the unequivocal conclusion that N5 of FMN~ox~ has a nucleophilic propensity and that the C′α---N5 bond is formed prior to α-ketoacid decarboxylation.

3.3.. Four-electron oxidation to benzoate   {#sec3.3}
-------------------------------------------

We propose that C4α-OOH-N5-acyl-FMN is the key intermediate in the four-electron oxidation of an α-hydroxyacid mediated by Hmo and its Y128F mutant on the basis of the following facts: (i) Hmo and its Y128F mutant catalyze the four-electron oxidation of an α-hydroxyacid via an α-ketoacid to an acid with one O atom from O~2~ incorporated into the terminal carboxylic group, (ii) H~2~O~2~ is not able to oxidize the α-ketoacid in the absence of Hmo or its Y128F mutant, (iii) the *pro-R* α-ketoacid is covalently linked to FMN~ox~ in the Y128F mutant, forming an N5-acyl-FMN~red~ adduct, (iv) the oxidation cascade stalls at the α-ketoacid using Hmo or its Y128F mutant with 5-deaza-FMN~ox~ in lieu of FMN~ox~ and (v) the *sp* ^3^ N5 in FMN~red~ is highly reactive, as exemplified in UbiX, a flavin prenyltransferase involved in bacterial ubiquinone biosynthesis (White *et al.*, 2015[@bb37]). The formation of the intermediate is somewhat similar to the mechanism proposed for EncM, which catalyses an oxidative Favorskii-type re­arrangement reaction (Teufel *et al.*, 2015[@bb29]). The major discrepancy, however, is that O~2~ in Hmo and its Y128F mutant mediates the transient formation of C4α-OOH-N5-acyl-FMN prior to its release as H~2~O~2~.

Superposition of the benzoylformate-liganded ternary complex of the Y128F mutant with that of the wild type shows no apparent discrepancies (r.m.s.d. of 0.06 Å) except for the *p*-OH group of Tyr128 ([Supplementary Fig. S4](#suppinfoanchor)). Given that the oxidative decarboxylation of an α-hydroxyacid is cata­lytically executed by the Y128F mutant, the *p*-OH group ought to play a crucial role in leverage of the oxidation cascade. This effect is commensurate with a recent report that a single mutation, C65D, of phenylacetone monooxygenase converts a monooxygenase to an oxidase (in contrast to this report) by facilitating the discharge of H~2~O~2~ (Brondani *et al.*, 2014[@bb4]). C4α-OOH-FMN~red~, which is a reactive intermediate in a typical monooxygenase/oxidase-catalyzed reaction, was modeled and optimized in the structure of Hmo, in which the *p*-OH group is within hydrogen-bonding distance (2.7 Å) of C4α-OOH \[Fig. 3[▸](#fig3){ref-type="fig"}(*e*)\]. On the basis of this model, the *p*-OH group is in a position to protonate C4α-OO^−^-FMN~red~ to form C4α-OOH-FMN~red~, thereby neutralizing or facilitating the discharge of H~2~O~2~ from C4α-OOH. In contrast, C4α-OO^−^-FMN~red~ may diverge in the absence of the *p*-OH group. One implication is that the Y128F mutant works like a monooxygenase, whereby Baeyer--Villiger-type reactions result. That is, the C4α-OO^−^ anion attacks the α-carbon (C′α) of *pro-R* benzoylformate to form a tetrahedral oxyanion species. Upon the collapse of the α-oxyanion the terminal carboxyl group migrates to the distal O atom of C4α-OO^−^ to form a mixed-anhydride species; subsequent hydrolysis would give rise to benzoate and formate (Torres Pazmiño *et al.*, 2010[@bb31]). This type of reaction, however, was ruled out because no benzoate was detected in the reactions catalyzed by the 5-deaza-FMN-containing Y128F mutant. This fact, however, underscores the importance of the *sp* ^3^ N5 of C4α-OO^−^-FMN~red~ in the four-electron oxidation reaction, where the reduced or polarized *sp* ^3^ N5 actually has a better Bürgi--Dunitz angle and is at a short distance from C′α of *pro-R* benzoylformate, favoring the formation of C4α-OO^−^-N5-alkyl-FMN~red~ before the release of H~2~O~2~.

3.4.. Proposed catalytic mechanism of oxidative decarboxylation   {#sec3.4}
-----------------------------------------------------------------

In a general four-electron oxidation reaction, one molecule of (*S*)-mandelate should theoretically yield two equivalents of H~2~O~2~. The molar ratio of H~2~O~2~ versus benzoate, however, did not follow this stoichiometry (it was much less than unity; Yeh *et al.*, 2019[@bb39]). This fact, in contrast, is consistent with a disproportionation reaction of FMN peroxide, in which one O atom goes to benzoate and the other ends up as water. To search for clues, we re-examined the active-site geometry of Hmo and its Y128F mutant liganded with substrates (mandelate or lactate) or products (benzoylformate or pyruvate). The redox-active center C4α=N5 of isoalloxazine is surrounded by a constellation of active-site residues \[Val78 and Ala79 at the bottom and Tyr(Phe)128 and His252 at the top\], where it is accessible only from the upper front side. The reaction center is sealed to form a narrow and low-dielectric milieu suitable for hydride transfer/electron tunneling when a substrate and redox-active center C4α=N5 approach each other. Interestingly, the substrate pair mandelate/benzoyl­formate fits better than the alternative pair lactate/pyruvate because of the bulky phenyl group in the former \[Figs. 3[▸](#fig3){ref-type="fig"}(*f*) and 3[▸](#fig3){ref-type="fig"}(*g*)\]. The redox chamber in the Y128F mutant, on the other hand, is not as tight as that in the wild type owing to the lack of the *p*-OH group \[Fig. 3[▸](#fig3){ref-type="fig"}(*h*)\]. This flaw is exacerbated when lactate (with a smaller methyl group) is used \[Figs. 3[▸](#fig3){ref-type="fig"}(*f*) and 3[▸](#fig3){ref-type="fig"}(*g*)\]. In this context, O~2~ is relatively accessible to FMN~red~ via a temporal space/tunnel to form C4α-OO^−^-FMN before the release of the α-ketoacid (the non-ping-pong mechanism). Meanwhile, the *pro*-*R* α-ketoacid is accessible by *sp* ^3^ N5 to form C4α-COOH-N5-oxyalkylate-FMN~red~. Upon decarboxyl­ation, a C4α-COOH-N5-aloxyl-FMN~red~ C′α carb­anion results. The C′α carbanion that intramolecularly attacks the distal O atom of C4α-OOH then leads to heterolytic cleavage of the peroxide scissile bond. Upon return of the C′α oxyanion, benzoate and H~2~O are formed in concert with the regeneration of FMN~ox~ (Fig. 5[▸](#fig5){ref-type="fig"}).

The peroxide anion radical:FMN semiquinone caged pair is likely to proceed through a single-electron transfer from FMN~red~ to O~2~ in a given flavoenzyme, where the reactivity depends on the active-site polarity ensemble of factors including bound water, charge distribution, hydrogen bonds, van der Waal forces *etc.* (Fagan & Palfey, 2010[@bb11]). The Y128C mutant (in which the bulky phenyl group is replaced by a sulfhydryl group) that can transform (*S*)-mandelate to benzoate was used to assess the extent of active-site perturbation. The structure of the Y128C mutant crystallized and soaked with (*S*)-mandelate revealed that the sulfhydryl (SH) group of the Y128C mutant has been oxidized to a sulfenyl group (S-OH), in contrast to the other sulfhydryl groups, which are not changed \[Fig. 3[▸](#fig3){ref-type="fig"}(*i*)\]. This result indicates that the sulfhydryl group of the Y128C mutant is relatively accessible and sensitive to the local unregulated reactive oxygen species (ROS; Chaiyen *et al.*, 2012[@bb6]).

4.. Conclusions   {#sec4}
=================

The present studies allow us to gain mechanistic insights into the reactions catalyzed by both Hmo and its Y128F mutant, in which substrate reorientation, active-site perturbation and spatiotemporal crowdedness are pivotal factors that influence the dioxygen accessibility and reaction order of the FMN~red/ox~:α-ketoacid pair in the reactions mediated by Hmo and its Y128F mutant. Given the Y128F mutation, the original reactivity of Hmo is perturbed. One stark contrast is that the electrophilic FMN~ox~ is polarizable to an ylide-like species. This species is capable of attacking an α-ketoacid to form an N5-acyl-FMN~red~ dead-end adduct, providing evidence for the first time that FMN~ox~ possesses a nucleophilic/electrophilic duality. Having confirmed the formation of the N5-acyl-FMN~red~ adduct, both the nucleophilic propensity and positional preponderance of N5 of FMN~red~ prompt us to propose that the N5-alkanol-FMN~red~ C′α carbanion is the key intermediate in the oxidative decarboxylation reaction. This intermediate reacts with dioxygen in place to form a C4α-COOH-N5-aloxyl-FMN~red~ C′α carbanion species that subsequently undergoes an intramolecular disproportionation reaction to yield benzoate and FMN~ox~, thus accounting for the ThDP/PLP/NADPH-independent oxidative decarboxylation reaction. To this end, the *p*-OH group of Tyr128 that leverages the spatial and temporal leeway over the oxidation cascade was unexpected. The α-substituent on the α-hydroxy acid that influences the accessibility of dioxygen to the reaction center is another unexpected factor. A synthetic 5-deaza-FMN~ox~ cofactor in combination with an α-hydroxyamide or α-keto­amide positively supports the proposed mechanism, in which the loose ends that benzoate is a minor product of Hmo and the major product of the Y128F mutant are tied up. An unequivocal consolidation of the proposed mechanism would be provided by the physical capture or visualization of the C4α-COOH-N5-aloxyl-FMN~red~ C′α carbanion or other relevant intermediates, which however will require future studies using advanced spectroscopic and microscopic analysis on the submicrosecond time scale using, for example, the X-ray free-electron laser technique. The present structural and biochemical elucidation nonetheless strengthens the idea that the FMN cofactor is versatile and cooperates with the active-site residues and substrates in dictating the oxidation cascade.
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![The oxidation reactions catalyzed by Hmo and its Y128F mutant. (*a*) Hmo catalyzes a two-electron oxidation reaction to form benzoylformate from (*S*)-mandelate. (*b*) The Y128F mutant catalyzes a four-electron oxidative decarboxylation reaction from (*S*)-mandelate to benzoylformate and benzoic acid without freeing H~2~O~2~ during the reaction. (*c*) When benzoylformate is used as the substrate, the decarboxylated product benzoic acid cannot be formed by Hmo or its Y128F mutant in the presence or absence of H~2~O~2~.](d-75-00918-fig1){#fig1}

![Crystal structures of acyl-FMN~red~ adducts and inhibition mechanism by α-ketoacids. (*a*) Structures of acyl-FMN~red~ adducts in crystals of the Y128F mutant soaked with benzoylformate (left), phenylpyruvate (center) or oxaloacetate (right). The flavin adducts all are at the *si*-face of the isoalloxazine ring. (*b*) LC traces and mass spectra of FMN (i) and phenylacetyl-FMN~red~ (ii). (*c*, *d*) Weighted 2*F* ~o~ − *F* ~c~ electron-density maps (gray) and unbiased *F* ~o~ − *F* ~c~ difference OMIT electron-density maps (blue) for FMN in Hmo (*c*) and the Y128F mutant (*d*) without (left) or with a ligand (*S*-mandelate, center; benzoylformate, right), where the extent of polarization is justified by OMIT electron density (the wild type or Y128F mutant and the absence or presence of a ligand seem to be key factors). The 2*F* ~o~ − *F* ~c~ electron-density map is contoured at 2σ; the unbiased *F* ~o~ − *F* ~c~ OMIT difference electron-density map is contoured at 4σ. Free ligands, FMN, FMN adducts and active-site residues are colored cyan, yellow, orange and green, respectively. See [Supplementary Figs. S3(*a*)](#suppinfoanchor), [S3(*b*)](#suppinfoanchor) and [S2(*c*)](#suppinfoanchor) for stereoviews and *F* ~o~ − *F* ~c~ difference electron-density maps.](d-75-00918-fig2){#fig2}

###### 

The effect of 4-OH of Tyr128 on polarization, hydrogen-bond networking and reactivity. (*a*, *b*) A close-up view of the wedge-shaped electron density on top of C4α=N5 of FMN~ox~ shown by unbiased difference electron-density maps (blue, positive electron density) contoured at 4σ in the wild type (*a*) and the Y128F mutant (*b*), suggesting that the electrons in the π-orbital of C4α=N5 are polarized from C4α to N5 (to form a C4α^+^--N5^−^ ylide), with this being more significant in the Y128F mutant than in the wild type. (*c*, *d*) The point mutation Y128F disturbs the active-site hydrogen-bonding network between water, FMN and the catalytic dyad \[the Y128F mutant loses the hydrogen bond between Tyr128 and H~2~O (187) but gains a new hydrogen bond between His252 and H~2~O (257)\]. (*e*) Hydrogen peroxide was modeled at C4α, where the distance between Tyr128 and the terminal O atom of Cα-OOH is 2.7 Å. (*f*, *g*) The phenyl ring of benzoylformate, which is bulkier and takes up space, limits the access of dioxygen to the reaction center, while the methyl group of pyruvate, which is smaller and takes up less space, allows the access of dioxygen to the reaction center \[the phenyl ring that bulges out at the substrate entrance in (*f*) prohibits exposure of FMN~red~ to the bulk solvent, as opposed to the methyl group in (*g*) which allows exposure of FMN~red~ to the bulk solvent\]. Therefore, the size of the substrates is another factor in leverage of the oxidation cascade. (*h*) Aside from the active-site perturbation effect, the absence of the *p*-­OH group also introduces some space allowing access of O~2~ to the C4α redox-active center. (*i*) The sulfhydryl group (SH) of the Y128C mutant has been oxidized to a sulfenyl group (S-OH), as it is vulnerable to ROS generated in the active site. Free ligands, FMN and active-site residues are colored cyan, yellow and green, respectively.
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###### 

Spectra, synthesis, reaction and structure of 5-deaza-FMN. (*a*) UV--Vis spectra of FMN in Hmo and its Y128F mutant: (i) FMN~ox~ in Hmo (370/450 nm, green line), (ii) acyl-FMN~red~ in the Y128F mutant \[340 nm, blue line; addition of phenylpyruvate (PPY) for 2 h\], (iii) acylated FMN in redissolved Y128F mutant crystals/crystalloids soaked with PPY (acyl-FMN~red~, 340 nm, dotted blue line), (iv) FMN~red~ in Hmo \[a shoulder at 330 nm, red; addition of phenyllactate (PLA)\]. (*b*) (i) Chemical synthesis and LC purification of 5-deazariboflavin (the inset shows the mass spectrum of 5-deazariboflavin), (ii) enzymatic synthesis and LC purification of 5-deaza-FMN (the inset shows the mass spectrum of 5-deaza-FMN). (*c*) Enzymatic reactions of Hmo and its Y128F mutant harboring 5-deaza-FMN: (i) enzymatic reaction with Hmo harboring 5-deaza-FMN in the presence of *S*-mandelate, (ii) enzymatic reaction with the Y128F mutant harboring 5-deaza-FMN in the presence of *S*-mandelate, (iii) control reaction of wild-type Hmo in the presence of *S*-mandelate, (iv) control reaction of the Y128F mutant in the presence of *S*-mandelate. (*d*, *e*) Crystal structures of the Y128F mutant harboring 5-deaza-FMN soaked with *S*-mandelate (*d*) or phenyllactate (*e*), which have been transformed into benzoylformate or phenylpyruvate, respectively. Unlike FMN in the wild type or the Y128F mutant, no electron density emerges at the top of C5 or between C′α and C5. (*f*) The structure of an α-mandelamide--N5-FMN~red~ adduct in the crystal of the R163L mutant soaked with nondecarboxylable α-mandelamide (the chemical structure is shown). The flavin adduct is on the *si*-face of the isoalloxazine ring. The 2*F* ~o~ − *F* ~c~ electron-density map is contoured at 2σ. The unbiased *F* ~o~ − *F* ~c~ difference electron-density map is contoured at 4σ in positive electron density. Free ligands, FMN, FMN adducts and active-site residues are colored cyan, yellow, orange and green, respectively. See [Supplementary Figs. S2(*j*)--S2(*m*)](#suppinfoanchor) for stereoviews and 2*F* ~o~ − *F* ~c~ difference electron-density maps.
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![The proposed mechanisms of oxidative decarboxylation catalyzed by the Y128F mutant.](d-75-00918-fig5){#fig5}

###### Data-collection and refinement statistics for Hmo and its Y128F, Y128C and R163L mutants

###### 

Values in parentheses are for the highest resolution shell. SMA, (*S*)-mandelate; BF, benzoylformate; FMN, riboflavin mononucleotide; 5DAFMN, 5-­deazariboflavin mononucleotide; PPY, phenylpyruvate; MA_FMN, malonyl--FMN; MAAD_FMN, mandelamide--FMN.

                                                      Hmo                                                                 Hmo--SMA                                                            Hmo--BF                                                             Y128F                                                               Y128F--SMA                                                          Y128F--BF                                                           Y128F--5DAFMN                                                       Y128F--5DAFMN--BA
  --------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- -------------------------------------------------------------------
  PDB code                                            [5zzp](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=5zzp)   [5zzr](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=5zzr)   [6a08](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=6a08)   [6a13](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=6a13)   [6a0v](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=6a0v)   [6a19](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=6a19)   [6a1h](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=6a1h)   [6a1l](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=6a1l)
  Data collection                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
   Wavelength (Å)                                     1.0                                                                 1.0                                                                 1.0                                                                 1.0                                                                 1.0                                                                 1.0                                                                 1.0                                                                 1.0
   Space group                                        *I*422                                                              *I*422                                                              *I*422                                                              *I*422                                                              *I*422                                                              *I*422                                                              *I*422                                                              *I*422
    *a*, *b*, *c* (Å)                                 137.9, 137.9, 112.3                                                 137.7, 137.7, 111.6                                                 137.9, 137.9, 111.8                                                 137.5, 137.5, 112.0                                                 137.8, 137.8, 111.8                                                 137.9, 137.9, 112.3                                                 137.4, 137.4, 112.4                                                 137.7, 137.7, 111.6
   α, β, γ (°)                                        90, 90, 90                                                          90, 90, 90                                                          90, 90, 90                                                          90, 90, 90                                                          90, 90, 90                                                          90, 90, 90                                                          90, 90, 90                                                          90, 90, 90
   Resolution range (Å)                               30--1.39 (1.44--1.39)                                               30--1.31 (1.36--1.31)                                               30--1.55 (1.61--1.55)                                               30--1.70 (1.76--1.70)                                               30--1.39 (1.44--1.39)                                               30--1.55 (1.61--1.55)                                               30--1.36 (1.41--1.36)                                               30--1.40 (1.45--1.40)
    *R* ~merge~ [†](#tfn1){ref-type="table-fn"} (%)   3.7 (73.0)                                                          3.7 (67.0)                                                          4.0 (79.0)                                                          3.5 (69.2)                                                          4.3 (73.1)                                                          3.6 (75.0)                                                          2.8 (62.0)                                                          4.2 (81.0)
   〈*I*/σ(*I*)〉                                     36.1 (2.4)                                                          34.5 (2.3)                                                          43.1 (2.9)                                                          41.3 (3.1)                                                          41.0 (2.9)                                                          32.9 (2.7)                                                          41.2 (3.4)                                                          29.6 (2.4)
   Completeness (%)                                   99.9 (100.0)                                                        99.0 (100.0)                                                        100.0 (100.0)                                                       100.0 (100.0)                                                       100.0 (100.0)                                                       99.9 (100.0)                                                        99.9 (100.0)                                                        100.0 (100.0)
   Multiplicity                                       9.4 (9.4)                                                           9.8 (9.5)                                                           12.8 (11.2)                                                         11.2 (11.1)                                                         12.2 (12.0)                                                         9.6 (9.2)                                                           9.7 (9.4)                                                           10.5 (10.4)
  Refinement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
   Resolution range (Å)                               30--1.39 (1.44--1.39)                                               30--1.31 (1.36--1.31)                                               30--1.55 (1.61--1.55)                                               30--1.70 (1.76--1.70)                                               30--1.39 (1.44--1.39)                                               30--1.55 (1.61--1.55)                                               30--1.36 (1.41--1.36)                                               30--1.40 (1.45--1.40)
    *R* ~work~ [‡](#tfn2){ref-type="table-fn"} (%)    17.0 (28.0)                                                         16.6 (22.9)                                                         16.9 (22.0)                                                         17.8 (24.2)                                                         16.7 (22.9)                                                         15.7 (24.4)                                                         16.8 (23.0)                                                         17.5 (28.0)
    *R* ~free~ [§](#tfn3){ref-type="table-fn"} (%)    18.3 (30.0)                                                         17.7 (22.3)                                                         17.9 (20.1)                                                         20.0 (26.2)                                                         18.4 (23.1)                                                         17.3 (26.6)                                                         18.1 (26.0)                                                         18.6 (30.1)
   R.m.s. deviations                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
    Bond lengths (Å)                                  0.010                                                               0.009                                                               0.008                                                               0.018                                                               0.008                                                               0.009                                                               0.017                                                               0.006
    Bond angles (°)                                   1.41                                                                1.41                                                                1.26                                                                1.490                                                               1.3361                                                              1.460                                                               1.421                                                               0.982
   No. of reflections                                 100548                                                              112497                                                              75720                                                               58599                                                               98014                                                               74156                                                               114232                                                              104841
   No. of atoms                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
    Protein                                           2785                                                                2622                                                                2684                                                                2510                                                                2636                                                                2703                                                                2548                                                                2574
    Ligand/ion                                        31                                                                  53                                                                  65                                                                  31                                                                  53                                                                  53                                                                  31                                                                  55
    Water                                             403                                                                 402                                                                 329                                                                 316                                                                 400                                                                 400                                                                 440                                                                 335
    *B* factors (Å^2^)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
    Protein                                           18.2                                                                19.7                                                                19.1                                                                18.6                                                                16.9                                                                21.9                                                                18.4                                                                20.5
    Ligand/ion                                        10.7                                                                19.0                                                                20.6                                                                10.8                                                                17.8                                                                29.4                                                                12.1                                                                17.1
    Water                                             32.4                                                                33.9                                                                31.7                                                                32.1                                                                32.2                                                                37.3                                                                34.9                                                                26.6

                                                      Y128F--5DAFMN--BF                                                   Y128F--5DAFMN--PPY                                                  Y128F--PPY--FMN                                                     Y128F--MA_FMN                                                       Y128F--BF--FMN                                                      Y128C--BF                                                           R163L--MAAD_FMN
  --------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- -------------------------------------------------------------------
  PDB code                                            [6a1m](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=6a1m)   [6a1p](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=6a1p)   [6a1r](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=6a1r)   [6a21](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=6a21)   [6a23](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=6a23)   [5zzz](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=5zzz)   [6a3t](https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=6a3t)
  Data collection                                                                                                                                                                                                                                                                                                                                                                                                                                                             
   Wavelength (Å)                                     1.0                                                                 1.0                                                                 1.0                                                                 1.0                                                                 1.0                                                                 1.0                                                                 1.0
   Space group                                        *I*422                                                              **I*422*                                                            *I*422                                                              *I*422                                                              *I*422                                                              *I*422                                                              *I*422
    *a*, *b*, *c* (Å)                                 137.9, 137.9, 111.2                                                 138.0, 138.0, 111.1                                                 138.1, 138.1, 112.1                                                 137.6, 137.6, 112.1                                                 137.8, 137.8, 111.8                                                 138.2, 138.2, 112.1                                                 137.4, 137.4, 111.7
   α, β, γ (°)                                        90, 90, 90                                                          90, 90, 90                                                          90, 90, 90                                                          90, 90, 90                                                          90, 90, 90                                                          90, 90, 90                                                          90, 90, 90
   Resolution range (Å)                               30--1.55 (1.61--1.55)                                               30--1.51 (1.56--1.51)                                               30--1.65 (1.71--1.65)                                               30--1.50 (1.55--1.50)                                               30--1.65 (1.71--1.65)                                               30--1.45 (1.50--1.45)                                               30--2.51 (2.60--2.51)
    *R* ~merge~ [†](#tfn1){ref-type="table-fn"} (%)   3.9 (57.0)                                                          3.6 (72.1)                                                          4.4 (73.0)                                                          3.2 (64.3)                                                          3.8 (70.1)                                                          4.4 (69.2)                                                          10.1 (66.0)
   〈*I*/σ(*I*)〉                                     40.8 (2.4)                                                          30.4 (2.3)                                                          36.8 (3.16)                                                         40.0 (3.2)                                                          28.4 (2.0)                                                          33.5 (2.6)                                                          15.2 (2.4)
   Completeness (%)                                   99.7 (97.2)                                                         99.8 (98.3)                                                         100.0 (100.0)                                                       99.9 (100.0)                                                        99.3 (100.0)                                                        99.9 (100.0)                                                        99.9 (100.0)
   Multiplicity                                       11.4 (9.1)                                                          9.4 (7.7)                                                           12.2 (12.1)                                                         9.8 (9.8)                                                           9.1 (8.8)                                                           9.9 (9.9)                                                           9.5 (9.3)
  Refinement                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
   Resolution range (Å)                               30--1.55 (1.61--1.55)                                               30--1.51 (1.56--1.51)                                               30--1.65 (1.71--1.65)                                               30--1.50 (1.55--1.50)                                               30--1.65 (1.71--1.65)                                               30--1.45 (1.50--1.45)                                               30--2.51 (2.60--2.51)
    *R* ~work~ [‡](#tfn2){ref-type="table-fn"} (%)    17.8 (25.7)                                                         17.0 (26.1)                                                         16.3 (20.6)                                                         16.7 (22.4)                                                         17.3 (24.1)                                                         17.5 (22.8)                                                         17.8 (21.6)
    *R* ~free~ [§](#tfn3){ref-type="table-fn"} (%)    20.1 (26.5)                                                         19.7 (26.8)                                                         18.5 (22.5)                                                         19.0 (22.9)                                                         19.4 (24.9)                                                         19.2 (27.2)                                                         22.4 (29.1)
   R.m.s. deviations                                                                                                                                                                                                                                                                                                                                                                                                                                                          
    Bond lengths (Å)                                  0.018                                                               0.015                                                               0.019                                                               0.018                                                               0.006                                                               0.010                                                               0.008
    Bond angles (°)                                   1.501                                                               1.357                                                               1.529                                                               1.557                                                               1.173                                                               1.300                                                               1.29
   No. of reflections                                 75042                                                               83439                                                               64602                                                               84212                                                               59812                                                               93717                                                               17837
   No. of atoms                                                                                                                                                                                                                                                                                                                                                                                                                                                               
    Protein                                           2485                                                                2539                                                                2586                                                                2626                                                                2606                                                                2481                                                                2496
    Ligand/ion                                        53                                                                  44                                                                  41                                                                  37                                                                  51                                                                  42                                                                  43
    Water                                             298                                                                 331                                                                 303                                                                 375                                                                 301                                                                 357                                                                 91
    *B* factors (Å^2^)                                                                                                                                                                                                                                                                                                                                                                                                                                                        
    Protein                                           19.3                                                                22.2                                                                17.9                                                                19.0                                                                19.1                                                                18.7                                                                40.29
    Ligand/ion                                        14.8                                                                18.2                                                                11.7                                                                16.7                                                                16.6                                                                20.0                                                                40.89
    Water                                             34.2                                                                35.2                                                                30.2                                                                33.2                                                                30.4                                                                31.6                                                                38.94

*R* ~merge~ = , where 〈*I*(*hkl*)〉 is the average intensity value of the equivalent reflections.

*R* ~work~ = .

*R* ~free~ was calculated from 5% of data that were randomly excluded from refinement.

[^1]: These authors contributed equally to this work.
